Joel Michalek
Overview
Explore the profile of Joel Michalek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
673
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Balinda H, Kelly W, Kaklamani V, Lathrop K, Canola M, Ghamasaee P, et al.
Nat Commun
. 2024 Aug;
15(1):6707.
PMID: 39112464
Sacituzumab Govitecan (SG) is an antibody-drug conjugate that has demonstrated efficacy in patients with TROP-2 expressing epithelial cancers. In a xenograft model of intracranial breast cancer, SG inhibited tumor growth...
2.
Vallejo S, Mahalingam D, Court C, Ketchum N, Gelfond J, Michalek J, et al.
J Geriatr Oncol
. 2024 Jun;
15(7):101816.
PMID: 38902147
No abstract available.
3.
Gruslova A, Singh S, Hoyt T, Vela D, Vengrenyuk Y, Buja L, et al.
JACC Cardiovasc Imaging
. 2023 Nov;
17(4):448-450.
PMID: 37943235
No abstract available.
4.
Mahalingam D, Hanni S, Serritella A, Fountzilas C, Michalek J, Hernandez B, et al.
Oncotarget
. 2023 Oct;
14:890-892.
PMID: 37861386
No abstract available.
5.
Mercer J, Mabry J, Donly K, Michalek J, Jayaraman J
Pediatr Dent
. 2023 Aug;
45(4):307-315.
PMID: 37605355
The purpose of this study was to assess the knowledge, attitude, and training of pediatric dental residents and faculty on the management of patients who belong to the LGBTQ (lesbian,...
6.
Mahalingam D, Hanni S, Serritella A, Fountzilas C, Michalek J, Hernandez B, et al.
Oncotarget
. 2023 Jun;
14:622-636.
PMID: 37335291
Background: Androgen deprivation therapy (ADT) can lead to metabolic syndrome (MS) and is implicated in ADT-resistance. Metformin showed antineoplastic activity through mTOR inhibition secondary AMPK-activation. Materials And Methods: To investigate...
7.
Kelly W, Diaz Duque A, Michalek J, Konkel B, Caflisch L, Chen Y, et al.
Clin Cancer Res
. 2023 Apr;
29(13):2419-2425.
PMID: 37093199
Purpose: Glioblastoma represents the most common primary brain tumor. Although antiangiogenics are used in the recurrent setting, they do not prolong survival. Glioblastoma is known to upregulate fatty acid synthase...
8.
Solis-McCarthy J, Gelabert C, Michalek J, Sisson C
J Am Coll Emerg Physicians Open
. 2022 Dec;
3(6):e12856.
PMID: 36474708
Objectives: The purpose of this study was to determine the impact of progressively increasing continuous positive airway pressure (CPAP) on measurements of the caval index (CI) using bedside ultrasound at...
9.
Arora S, Tenner L, Sarantopoulos J, Morris J, Liu Q, Mendez J, et al.
Br J Cancer
. 2022 Jun;
127(6):1153-1161.
PMID: 35739299
Background: In metastatic colorectal cancer (mCRC), regorafenib (RGF), a multi-kinase inhibitor with angiogenic inhibition has modest effects on survival. We reported that autophagy modulation using hydroxychloroquine (HCQ), enhances the anticancer...
10.
Ochoa O, Rajan M, Garza 3rd R, Chrysopoulo M, Pisano S, Ledoux P, et al.
Plast Reconstr Surg
. 2022 May;
150(1):13e-21e.
PMID: 35500278
Background: This study aimed to determine benefits of the Enhanced Recovery After Surgery (ERAS) pathway implementation in free flap breast reconstruction related to postoperative narcotic use and health care resource...